and has received equipment research grants from GE Healthcare and Toshiba. Dr. Singh has reported that he has no relationships relevant to the contents of this paper to disclose. (Table 5) due to congenital heart disease and PAH due to chronic thromboembolic disease (3, 15) . On the basis of the study by Badagliacca et al. (9) and previous work, it is safe to say that RV dyssynchrony partners with adverse RV remodeling and dysfunction seen in PAH.
What is its true clinical significance, and whether it should be a distinct therapeutic target await testing in the forge of additional research and clinical use.
